Skip to main content
Midas Edge

Larimar Therapeutics, Inc.

For the period ended Apr 17, 2026. Filed Apr 20, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Apr 17, 2026 · Filed Apr 20, 2026

LRMR$2.39+3.0%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

PROXY STATEMENT

This Proxy Statement, with the enclosed proxy card, is being furnished to stockholders of Larimar Therapeutics, Inc. (the “Company”) in connection with the solicitation by our Board of proxies to be voted at our Annual Meeting and at any postponements or adjournments thereof. The Annual Meeting will be held on Tuesday, May 19, 2026, at 8:00 a.m., Eastern Time via the Internet at meetnow.global/MWXPCMG.

Notice of Annual Meeting of Stockholders and 2026 Proxy Statementvi
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.